Greenberger P A, Chow M J, Atkinson A J, Ambre J J, Patterson R
Clin Pharmacol Ther. 1986 Feb;39(2):163-8. doi: 10.1038/clpt.1986.28.
Prednisolone pharmacokinetics were compared in seven patients with asthma managed by alternate-day prednisone therapy and in seven patients with asthma requiring daily doses of prednisone. Steroid requirements of these patients were carefully characterized and had been stable for at least 12 months. Prednisolone volume of distribution, elimination clearance, and elimination t1/2 averaged 0.606 +/- 0.061 and 0.553 +/- 0.162 L/kg, 2.28 +/- 0.43 and 1.93 +/- 0.54 ml/min/kg, and 204 +/- 44 and 214 +/- 19 minutes in patients receiving alternate-day or daily prednisone therapy, respectively. These results indicate that differences in these pharmacokinetic parameters do not account for the well-established clinical observation that some patients require daily prednisone doses and that their disease cannot be managed with alternate-day steroid therapy.
对7例采用隔日泼尼松治疗的哮喘患者和7例需要每日服用泼尼松的哮喘患者的泼尼松龙药代动力学进行了比较。仔细描述了这些患者的类固醇需求情况,且这些需求至少已稳定12个月。接受隔日或每日泼尼松治疗的患者,其泼尼松龙的分布容积、清除率和消除半衰期平均分别为0.606±0.061和0.553±0.162L/kg、2.28±0.43和1.93±0.54ml/(min·kg)、204±44和214±19分钟。这些结果表明,这些药代动力学参数的差异并不能解释已得到充分证实的临床观察结果,即一些患者需要每日服用泼尼松剂量,且其疾病无法通过隔日类固醇疗法进行控制。